• 1 Year Returns: 14.50%
• 3 Year Returns: 26.69%
• 5 Year Returns: 24.28%

• Pharmaceuticals | 60.37%
• Labs & Life Sciences Services | 26.25%
• Others | 11.17%
• Fertilizers & Agro Chemicals | 1.12%
• IT Services & Consulting | 0.51%

• Sun Pharmaceutical Industries Ltd | 11.64%
• CASH / NET CURRENT ASSET | 8.92%
• Apollo Hospitals Enterprise Ltd | 6.22%
• Cipla Ltd | 5.83%
• Aurobindo Pharma Ltd | 5.73%

• Equity | 90.84%
• Cash & Equivalents | 9.16%

The alpha ratio for the Tata India Pharma & Healthcare Fund is 2.97

Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.

The volatility or standard deviation for the Tata India Pharma & Healthcare Fund is 15.33

Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

The Sharpe ratio for the Tata India Pharma & Healthcare Fund is 0.71

The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

The Sortino Ratio for the Tata India Pharma & Healthcare Fund is 0.07

The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.